NTHU Researchers Unveil the Mystery of Cancer Cells' Sugar Addiction NTHU researchers uncover how cancer cells’ sugar addiction fuels growth, paving the way for potential new cancer treatments.

Anti-Cancer Drugs Publishes Preclinical Data Demonstrating the Broad Antineoplastic Activity of Panavance’s Misetionamide (GP-2250) Misetionamide showed broad antineoplastic activity in 15 different cancer types including multiple human cancer cell lines with no detrimental effect on normal cells Misetionamide reduces energy...